Intrauterine therapy for fetal supraventricular tachycardia in a twin pregnancy.
A case of a twin pregnancy in which one fetus developed hydrops secondary to supraventricular tachycardia was detected at 21 weeks' gestation. Transplacental digoxin therapy successfully converted the supraventricular tachycardia to a normal sinus rhythm without evidence of maternal or fetal side-effects. The pregnancy proceeded to term and elective cesarean section was carried out at 37 weeks' gestation.
Tanawattanacharoen
Somchai
S
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. fmedstn@md2.md.chula.ac.th
Uerpairojkit
Boonchai
B
Prechawat
Somchai
S
Manotaya
Saknan
S
Charoenvidhya
Dhiraphongs
D
D000328:Adult; D002585:Cesarean Section; D004077:Digoxin / Q000627:therapeutic use; D004200:Diseases in Twins; D017809:Fatal Outcome; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000188:drug therapy*; D005865:Gestational Age; D006801:Humans; D015160:Hydrops Fetalis / Q000150:complications / Q000000981:diagnostic imaging; D008297:Male; D011247:Pregnancy; D011256:Pregnancy Outcome; D011272:Pregnancy, Multiple; D013617:Tachycardia, Supraventricular / Q000175:diagnosis / Q000188:drug therapy*; D016216:Ultrasonography, Prenatal
D004077:Digoxin